La transplantation intestinale

Translated title of the contribution: Small intestinal transplantation

Olivier Goulet, Dominique Jan, Nicole Brousse, Danielle Canioni, Sabine Sarnacki, Claude Ricour, Yann Révillon

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based PN. Intestinal transplantation is henceforth possible and appears now, under certain conditions, the logical therapeutic option. Since 1985, more than 180 small-bowel grafts have been performed, involving the isolated small bowel with or without the colon (38%), the liver plus the small bowel (46%) or several more organs (16%). Two thirds of the recipients were under 20 years of age, and indications were short-bowel syndrome (64%), severe intractable diarrhea (13%), abdominal cancer (13%) or chronic intestinal pseudo-obstruction syndrome (8%). Fifty one per cent of the patients survived more than two years after graft. Patient and graft survival depend on the type of immunosuppression, i.e. CyA or FK506. The results must be carefully interpreted as they represent the first experience in numerous centers using different immunosuppression protocols, without any randomization. Results obtained in the largest of these centers are more indicative of the current situation. This article reviews the main aspects of human intestinal transplantation with special focus on graft rejection in terms of immunohistochemical expression which is decisive for diagnosis and specific treatment. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or lengthily dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication of transplantation must be carefully weighed up in terms of iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be considered. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is indicated only in case of life-threatening progressive cirrhogenic liver disease.

Translated title of the contributionSmall intestinal transplantation
Original languageFrench
Pages (from-to)323-334
Number of pages12
Issue number3
StatePublished - Mar 1997
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Small intestinal transplantation'. Together they form a unique fingerprint.

Cite this